The given bar chart illustrates the percentage distribution of a drug company’s total sales across three regions—America, Europe, and Asia—from 2002 to 2006.
In 2002, America had the highest share of sales at 41%, while Europe and Asia accounted for 34% and 25%, respectively. Over the years, America’s share declined steadily, reaching its lowest at 27% in 2004 before slightly increasing to 30% by 2006. Conversely, Asia showed a consistent rise in sales contribution, growing from 25% in 2002 to 40% in 2006, making it the region with the highest percentage in the final year.
Europe experienced fluctuations, peaking at 38% in 2004 but later declining to 30% in 2006. This suggests a shift in the market dynamics, with Asia gaining a stronger foothold while America and Europe saw relative declines.
Overall, the trend indicates a growing dominance of the Asian market in the company’s sales, while America’s sales proportion decreased significantly over time. Europe maintained a moderate but fluctuating share.
